The recent disruptions in global supply have highlighted the value of securing vital medications like Ivermectin. Relying on overseas manufacturers exposes regions to potential vulnerabilities, including transportation delays, expense fluctuations, and even political concerns. Moving towards domestic procurement of Ivermectin offers a multitude of